Sonoma Pharmaceuticals, Inc. (SNOA) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'26 | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|
| Cash from Operations | -519K | -764K | -95K | -2.02M | 565K | 354K | 354K | -912K | 152K | 565K | -1.23M | -912K | -2.44M | -348K | -1.83M | -1.53M | -1.4M | -326K | -1.3M | -1.22M |
| Operating CF Margin % | -9.33% | -17.57% | -1.7% | -50.19% | 15.05% | 9.93% | 9.89% | -26.89% | 4.42% | 18.01% | -45.08% | -26.61% | -80.99% | -11.82% | -54.94% | -38.49% | -60.7% | -11.23% | -34.83% | -33.2% |
| Operating CF Growth % | -191.86% | -315.82% | -126.84% | -120.94% | 271.71% | -37.35% | 128.76% | 0% | 106.23% | 262.36% | 32.73% | 40.51% | -74.98% | -6.75% | -40.34% | -25.35% | 5.49% | -143.7% | -256.28% | 46.41% |
| Net Income | -581K | -577K | -776K | -1.24M | -928K | -610K | -610K | -1.14M | -1.07M | -928K | -1.48M | -1.14M | -1.31M | -1.94M | -1.02M | -887K | -2.94M | -944K | -100K | -1.1M |
| Depreciation & Amortization | 33K | 39K | 31K | 36K | 33K | 35K | 35K | 39K | 41K | 33K | 45K | 39K | 34K | 32K | 28K | 31K | 49K | 37K | 52K | 48K |
| Stock-Based Compensation | 135K | -27K | 90K | 57K | 13K | 14K | 14K | 107K | 0 | 13K | 130K | 107K | 100K | 0 | 0 | 214K | 212K | 56K | 55K | 59K |
| Deferred Taxes | -431K | -81K | 188K | 93K | -19K | 66K | 66K | 122K | -201K | -19K | 54K | 122K | 0 | 0 | 40K | -40K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -515K | -217K | 174K | -448K | 0 | -55K | -55K | 55K | 230K | 0 | -144K | 55K | 70K | 241K | 113K | 0 | -1.99M | -150K | -723K | 0 |
| Working Capital Changes | 840K | 99K | 198K | -512K | 1.47M | 904K | 904K | -92K | 1.15M | 1.47M | 168K | -92K | -1.34M | 1.32M | -994K | -851K | 3.28M | 675K | -588K | -232K |
| Change in Receivables | -168K | 340K | 215K | -216K | 646K | 43K | 43K | -470K | -9K | 646K | 184K | -470K | -67K | 289K | -87K | -73K | 2.03M | 537K | -483K | -112K |
| Change in Inventory | 19K | -40K | 291K | -652K | -309K | -256K | -256K | -114K | 277K | -309K | 173K | -114K | 162K | 285K | -272K | -175K | 266K | -426K | 69K | -9K |
| Change in Payables | 282K | 229K | -448K | 1.03M | 645K | 37K | 37K | 182K | -266K | 645K | -82K | 182K | -511K | 205K | -981K | 423K | 32K | -288K | 71K | 28K |
| Cash from Investing | -29K | -47K | -47K | -106K | -2K | -26K | -26K | -5K | 18K | -2K | -2K | -5K | -82K | 34K | -187K | -23K | -61K | 0 | 11K | -49K |
| Capital Expenditures | -29K | -10K | -47K | -106K | -2K | -26K | -26K | -5K | 3K | -2K | -2K | -5K | -190K | -31K | -25K | -23K | -62K | -1K | -25K | -49K |
| CapEx % of Revenue | 0.52% | 0.23% | 0.84% | 2.64% | 0.05% | 0.73% | 0.73% | 0.15% | 0.09% | 0.06% | 0.07% | 0.15% | 6.3% | 1.05% | 0.75% | 0.58% | 2.7% | 0.03% | 0.67% | 1.33% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -37K | 0 | 0 | 0 | 0 | 0 | 0 | 15K | 0 | 0 | 0 | 108K | 65K | -162K | 0 | 1K | 1K | 36K | 0 |
| Cash from Financing | 387K | 210K | 242K | -58K | 708K | 1.44M | 1.44M | 636K | 622K | 708K | -129K | 636K | 3.37M | -318K | -178K | -387K | 222K | 463K | 6.92M | -209K |
| Debt Issued (Net) | -51K | -56K | -81K | -81K | -82K | -122K | -122K | -119K | -94K | -82K | -129K | -119K | 415K | -229K | -215K | -350K | 222K | -199K | -198K | -199K |
| Equity Issued (Net) | 161K | 266K | 21K | 23K | 789K | 1.54M | 1.54M | 748K | 338K | 789K | 0 | 748K | 2.87M | -89K | 0 | 0 | 0 | 662K | 7.11M | -10K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10K |
| Other Financing | 277K | 0 | 302K | 0 | 1K | 25K | 25K | 7K | 378K | 1K | 0 | 7K | 89K | 0 | 37K | -37K | 0 | 0 | 10K | 0 |
| Net Change in Cash | -162K | -474K | 138K | -1.77M | 1.16M | 1.49M | 1.49M | -539K | 722K | 1.16M | -1.41M | -539K | 1.19M | -717K | -2.23M | -1.81M | -1.13M | 137K | 5.58M | -1.41M |
| Free Cash Flow | -548K | -811K | -142K | -2.12M | 563K | 328K | 328K | -917K | 155K | 563K | -1.23M | -917K | -2.63M | -379K | -1.85M | -1.56M | -1.46M | -327K | -1.33M | -1.27M |
| FCF Margin % | -9.85% | -18.65% | -2.53% | -52.83% | 15% | 9.2% | 9.16% | -27.04% | 4.51% | 17.94% | -45.15% | -26.76% | -87.29% | -12.87% | -55.69% | -39.07% | -63.4% | -11.27% | -35.5% | -34.53% |
| FCF Growth % | -197.34% | -347.26% | -143.29% | -131.3% | 263.23% | -41.74% | 126.6% | 0% | 105.89% | 248.55% | 33.53% | 41.07% | -80.58% | -15.9% | -39.58% | -22.33% | 1.62% | -148.88% | -223.36% | 45.5% |
| FCF per Share | -0.31 | -0.47 | -0.09 | -1.29 | 0.45 | 0.22 | 0.32 | -1.08 | 0.20 | 1.03 | -2.39 | -1.86 | -5.62 | -1.22 | -5.98 | -5.02 | -5.26 | -1.06 | -5.67 | -6.08 |
| FCF Conversion (FCF/Net Income) | 0.89x | 0.93x | 0.18x | 1.62x | -0.73x | -0.38x | -0.58x | 0.80x | -0.14x | -0.65x | 0.83x | 0.64x | 1.87x | 0.18x | 1.80x | 1.73x | 0.47x | 0.35x | 13.04x | 1.11x |
| Interest Paid | 0 | 5K | 3K | 0 | 0 | 3K | 3K | 0 | 0 | 0 | 0 | 5K | 5K | 0 | 0 | 4K | 12K | 4K | 4K | 4K |
| Taxes Paid | 0 | 247K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 55K | 0 | 0 | 0 | 0 |